SCHEMBL7294526

SCHEMBL7294526

CCOC(=O)[C@H](Cc1ccc(OP)c(O)c1)NC(=O)[C@H](C)N

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.39
▸ ALOX15 P16050 2/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ EGFR P00533 1/20 0.37
▸ PPID Q08752 1/20 0.37
▸ CARM1 Q86X55 3/20 0.37
▸ PRMT6 Q96LA8 3/20 0.37
▸ IARS1 P41252 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ TSHR P16473 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ TUBB1 Q9H4B7 1/20 0.36
▸ TACR1 P25103 1/20 0.36
▸ TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7296838 0.89 PPID (0.41) LCKALDH1A1PPID
SCHEMBL7294519 0.87 GRB2 (0.46) LCKALDH1A1ALOX15ALOX12EGFR
SCHEMBL7302581 0.86 ALDH1A1 (0.43) LCKALDH1A1ALOX15ALOX12EGFR
SCHEMBL7295209 0.81 ALOX15 (0.46) LCKALDH1A1ALOX15ALOX12EGFR
SCHEMBL7303478 0.80 DRD1 (0.53) LCKPPIDTACR1
SCHEMBL9777176 0.79 CAPN1 (0.54) —
SCHEMBL7296829 0.79 GRB2 (0.47) LCKPPID
SCHEMBL11850734 0.78 LCK (0.53) LCKALDH1A1ALOX15ALOX12EGFR
SCHEMBL7298903 0.77 LCK (0.42) LCKALDH1A1EGFRPPIDMAPT
SCHEMBL10953335 0.77 ALDH1A1 (0.58) ALDH1A1TACR1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0393781-B1 Dopamine pro-drug ZAMBON SPA (IT) 1995-02-08 — — EP disclosed
US-5073547-A DOPAMINE PRO-DRUG SIMES SOCIETA ITALIANA MEDICINALI E SINTETICI S.P.A. (IT) 1991-12-17 — — US disclosed
EP-0393781-A2 Dopamine pro-drug ZAMBON GROUP S.p.A. (IT) 1990-10-24 — — EP disclosed
Send feedback